AnnualReports.com – the leading provider of online annual reports to individual and institutional investors.
ImmunoGen Inc.
Click here to visit Company website
ImmunoGen, Inc. engages in the research and development of antibody-based anticancer therapeutics in the United States. The company develops its product candidates using its Targeted Antibody Payload (TAP) technology.
View Online Reports:
Order Free Hardcopy
You can request a free hardcopy of this report mailed to you by clicking the button below.
No investor fact sheets added yet
No responsibility reports added yet
